Riskpilot← Back to searchSign inGet full accessNORDLYS FOTTERAPI AS
ASActiveOrg 926183397Kjosveien 24, 9515 AltaOther human health activities n.e.c. · NACE 8699Est. 20201 employees
Revenue 2025
NOK 748K
+20% vs 2024
EBITDA margin
14.4%
+116% vs 2024
Equity ratio
60.5%
Financial strength
Net profit 2025
NOK 74K
+212% vs 2024
| Revenue | NOK 748K | +20% |
| EBITDA | NOK 108K | +116% |
| Net profit | NOK 74K | +212% |
| Total assets | NOK 250K | +42% |
| Equity | NOK 151K | +97% |
| Employees | 1 | — |
Legal name
NORDLYS FOTTERAPI AS
Org number
926183397
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
15. desember 2020
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Fotterapi og andre produkter/tjenester som naturlig hører sammen med dette , herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Kjosveien 24, 9515 Alta
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 490 | 534 | 603 | 625 | 748 |
| Staff expenses | −178 | −283 | −329 | −326 | −372 |
| EBITDA | 24 | 21 | 27 | 50 | 108 |
| Depreciation & amort. | −12 | −14 | −22 | −22 | −22 |
| EBIT | 11 | 7 | 5 | 28 | 86 |
| Net financials | 0 | 0 | 0 | 2 | 9 |
| Profit before tax | 11 | 7 | 5 | 31 | 95 |
| Tax | 2 | 2 | −0 | 7 | 21 |
| Net profit | 9 | 5 | 4 | 24 | 74 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 184 | 166 | 196 | 176 | 250 |
| Equity | 44 | 49 | 53 | 77 | 151 |
| Long-term debt | 85 | 17 | 15 | 18 | 12 |
| Short-term debt | 55 | 100 | 128 | 81 | 87 |
| Total debt | 140 | 117 | 143 | 99 | 99 |
EBITDA margin
14.4%
This company
15.8%
Market median
-9% vs market
20212025
Equity ratio
60.5%
This company
38.2%
Market median
+58% vs market
20212025
Return on equity
49.1%
This company
18.4%
Market median
+167% vs market
20212025
Net profit margin
9.9%
This company
8.1%
Market median
+22% vs market
20212025
Asset turnover
3.00×
This company
1.12×
Market median
+168% vs market
20212025
Debt / equity
0.65×
This company
0.62×
Market median
+5% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NORDLYS FOTTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lisa Børstrand Sætermo | Board of Directors | 0 companies |
| Jorid Berntzen Martinsen | Board of Directors | 0 companies |
| Monica Børstrand | Chairman | 0 companies |